Professional Documents
Culture Documents
Spirometry
Isaac M. Goldberg, MD
Faculty, San Jacinto Methodist Hospital Family Medicine Residency, Baytown,
TX
Educational Objectives
At the end of this presentation, the
learner should be able to …
• Utilize spirometry to diagnose and stage
COPD
• Overcome barriers to the use of office
spirometry
• Achieve confidence with spirometry
interpretation
Background
Objective measure of airway function for accurate
diagnosis of Chronic Obstructive Pulmonary
Disease (COPD)
World Health Organization Global Obstructive Lung
Disease Consensus/ Evidence guideline (GOLD)
American Thoracic Society (ATS)
European Respiratory Society (ERS)
National Committee for Quality Assurance (NCQA)
Background
Alternate ways to diagnose COPD
Clinical Findings Late
- Increased AP diameter, tympanitic chest
- Signs of respiratory distress
Peak flow reading not adequately sensitive or specific
Radiographic findings occur late in disease
CT scanning more accurate, but findings also occur
late in disease
Background
Who should receive spirometry?
Early diagnosis relies on the recognition of the clinical
features
- Persistent cough
- Chronic sputum production
- Breathlessness on exertion
- Reduction in activity (often attributed to natural aging)
Reversibility = Asthma!
Measurements
Pre-Bronchodilator Post-Bronchodilator
Predicted Measured % Measured % % change
FVC 2.66 1.32 50 1.26 47 -4
FEV1 2.02 0.54 26 0.50 25 -6
FEV1/FVC 76 41 -35 39 -37 -2
PEF 315 114 36 120 38 5
FEF 25 4.96 0.40 8 0.30 6 -28
FEF 50 2.85 0.20 7 0.20 7 -----
FEF 75 0.78 0.10 13 ----- ----- 198
FEF 25-75 1.02 0.19 10 0.18 10 -6
Measurements
Severity of obstruction
FEV1 % of predicted
Mild >80
Moderate 50 to 79
Severe 30 to
Very severe <30
Severity of restriction
FVC % of predicted
Mild >65 to 80
Moderate >50 to 65
Severe <50
Case Study 1
A 53-year-old white male presents for annual
visit. Although he quit 10 years ago he is a
previous cigarette smoker with a 20 pack-year
history. During the past 12 months, he has had
3 episodes of bronchitis. His history of tobacco
use and recent episodes of acute bronchitis lead
you to perform spirometry.
Results
Pre-Bronchodilator Post-Bronchodilator
Predicted Measured % Measured % % change
FVC 4.65 4.65 100 4.95 106 6
FEV1 3.75 3.13 83 3.34 89 6
FEV1/FVC 80 67 -13 67 -13 0
PEF 511 462 90 522 102 12
FEF 25 7.86 5.7 73 6.00 76 5
FEF 50 4.46 2.3 52 2.10 47 -9
FEF 75 1.75 .5 29 0.60 35 18
FEF 25-75 3.76 1.77 47 1.78 47 0
Results
Pre-Bronchodilator Post-Bronchodilator
Predicted Measured % Measured % % change
FVC 4.65 4.65 100 4.95 106 6
FEV1 3.75 3.13 83 3.34 89 6
FEV1/FVC 80 67 -13 67 -13 0
Is there obstruction?
FEV1/FVC = 67% of predicted; therefore, obstruction present
Is there restriction?
FVC = 100% of predicted; therefore, no restriction present
Results
Pre-Bronchodilator Post-Bronchodilator
Predicted Measured % Measured % % change
FVC 4.65 4.65 100 4.95 106 6
FEV1 3.75 3.13 83 3.34 89 6
FEV1/FVC 80 67 -13 67 -13 0
Yes No
No Yes Yes No
Further Testing with Suspect Suspect
Full PFT’s Asthma COPD
Obstruction?
FEV1/FVC = 60%; therefore, obstruction present
Restriction?
FVC = 51% of predicted; therefore, restriction present
Results
Pre-Bronchodilator Post-Bronchodilator
Predicted Measured % Measured % % change
FVC 3.78 1.92 51 2.7 71 34
FEV1 3.24 1.11 34 1.61 50 36
FEV1/ FVC 86 58 -28 60 -26 3
No
Yes No
Lowry 1998
Results
“Full” Pulmonary Function Testing (PFT’s)
Assessment of Oxygenation
- Transcutaneous oxygen saturation
- Arterial blood gasses
Diffusion test to evaluate alveolar exchange (DLCO)
Plethysmography
- To objectively assess lung volumes
- Delineate air-trapping versus restriction
May also include Spirometry
Spirometry and Smoking Cessation